Learn about Brink Tx as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy.

Colossal Laboratories & Biosciences claimed they had resurrected the long-extinct Ice Age dire wolf using gene editing ...

The global gene therapy market is projected to grow at a significant CAGR of 20% from 2024 to 2029. This growth is driven by ...

Growth Drivers include demand for protein-based drugs, rise in chronic disease prevalence, precision medicine expansion, biotech advancements, and AI-driven design tools.Dublin, April 14, 2025 (GLOBE ...

A phase 1/2 trial of CRISPR-engineered eTIL therapy KSQ-004EX for advanced solid tumors has dosed its first patient.

Gene editing technologies have cemented their place as a valued method in the biological toolkit used by researchers around the globe.

Colossal Biosciences—the company known for its plan to bring back the woolly mammoth—has just bio-engineered the first dire ...

A research team from Helmholtz Munich and the Technical University of Munich has developed an advanced delivery system that ...

A research team has developed an advanced delivery system that transports gene-editing tools based on the CRISPR/Cas9 gene-editing system into living cells with significantly greater efficiency than ...

Semarion's SemaCyte® technology transforms adherent cell assays, enabling faster, automated workflows that enhance ...

Dr. Gorka Santos, CellEDIT Sales Manager, will present the CellEDIT Service for precise CRISPR-based genome editing, even in challenging cancer models. USA Sales Tour April – May 2025 Drs. Gerecsei ...